The In-House Counsel Forum on Government Regulation of Medical Device Pricing & Reimbursement
20 June 2007
Partner Janice Anderson and Partner Judith Waltz will be presenting at the American Conference Institute’s (ACI) “The In-House Counsel Forum on Government Regulation of Medical Device Pricing & Reimbursement: Overcoming Coverage, Coding, and Payment Challenges to Increase Clients’ Market Share,” June 20 – 21, 2007 in Chicago, IL.
Topic: Grappling with the Reimbursement Implications Associated with Off-Label Uses of Medical Devices
Date: Thursday, June 21, 2007
Time: 11:45 a.m. – 12:45 p.m.
Date: Thursday, June 21, 2007
Time: 11:45 a.m. – 12:45 p.m.
- Analyzing Medicare coverage rules for non-approved devices
- Strategies for dealing with national and local Medicare coverage issues
- Investigational cardiac device litigation update
- Yale-New Haven v. Leavitt (2nd Circuit)
- United States ex rel. Sikkenga v. Regence Blue Cross Blue Shield of Utah (10th Circuit)
- Yale-New Haven v. Leavitt (2nd Circuit)
- Steering clear of potential liability under the beneficiary inducement prohibition if the device is given away
- Preventing claims under the False Claims Act and other fraud and abuse statutes for off-label marketing and providing inappropriate reimbursement advice to customers
- Ensuring that your compliance program complies with off-label rules and prevents the giving of reimbursement advice
Speakers:
- Janice A. Anderson, Partner, Foley & Lardner LLP (Chicago, IL)
- Thomas S. Crane, Partner, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (Boston, MA)
Topic: Reimbursement-Related Compliance Issues and the Government Investigations and Enforcement Actions that Follow
Date: Thursday, June 21, 2007
Date: Thursday, June 21, 2007
Time: 2:00 p.m. – 3:00 p.m.
- Potential anti-kickback and False Claims Act violations that stem from reimbursement policy
- Criminal and civil liability risk areas where reimbursement policy is perceived as pricing manipulation of off-label promotion
- Educating sales force on coverage issues
- Incorporating reimbursement options into DTC campaigns
- Current DOJ and OIG enforcement priorities and targets
- Avoiding enforcement triggers: what to do if your client is engaging in one of these red flag practices
- Government investigation tactics
- Intervening in device qui tam suits: key factors the government will consider in determining whether to join the suit
Speakers:
- Judy Waltz, Partner, Foley & Lardner LLP (San Francisco, CA)
- Kenneth J. Yood, Partner, Paul, Hastings, Janofsky & Walker LLP (Los Angeles, CA)
People
Related Insights
21 March 2025
IP Litigation Current
Federal Circuit Opens the Door to Additional Domestic Industry Investment: “Ordinary Importer” No Longer
In its recent decision in Lashify, Inc. v. International Trade Commission, the Federal Circuit opened the door for patent owners to include expanded categories of domestic investment to satisfy the economic prong of the domestic industry requirement under Section 337(a)(3)(B).
21 March 2025
Manufacturing Industry Advisor
Federal Court Rejects FCA’s “65%-100%” Language as Insufficient to Constitute the Necessary Quantity Term in a Requirements Contract—A Win for Suppliers
A recent federal court decision marks an important win for automotive suppliers in the ongoing debate over what constitutes a valid requirements contract under Michigan law following the Michigan Supreme Court’s decision in MSSN, Inc. v. Airboss Flexible Products Co. (2023).
27 April 2025
Events
Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value
Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.